Aton (EPA:ALTAO)
France · Delayed Price · Currency is EUR 0.0060
0.00 (0.00%)
At close: Feb 20, 2026
Aton Market Cap
Aton has a market cap or net worth of €4.97 million as of February 20, 2026. Its market cap has decreased by -37.90% in one year.
Market Cap
4.97M
Enterprise Value
9.42M
Revenue
656.93K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.01
Market Cap Chart
Since October 15, 2019, Aton's market cap has decreased from 5.02M to 4.97M, a decrease of -1.05%. That is a compound annual growth rate of -0.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 4.97M | -16.67% |
| Dec 31, 2025 | 5.96M | -24.72% |
| Dec 31, 2024 | 7.92M | 1.62% |
| Dec 29, 2023 | 7.79M | -53.93% |
| Dec 30, 2022 | 16.92M | -44.59% |
| Dec 31, 2021 | 30.53M | -41.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| genOway Société anonyme | 22.77M |
| Aelis Farma | 18.76M |
| GenSight Biologics | 17.95M |
| Poxel | 14.78M |
| NFL Biosciences | 14.07M |
| Plant Advanced Technologies | 9.36M |
| Oncodesign Precision Medicine Société anonyme | 9.04M |
| TME Pharma | 6.87M |